{"gene":"DFFB","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1998,"finding":"DFFB (CPAN/DFF40) is a caspase-activated 40 kDa endonuclease sufficient to degrade naked DNA and induce apoptotic morphology and DNA fragmentation in naive nuclei. Its activity is regulated by DFF45, which is required for CPAN expression and stabilization in an inactive state; proteolytic cleavage of DFF45 by caspases leads to dissociation of DFF45 fragments from CPAN and activation of CPAN endonuclease activity.","method":"Protein purification from Jurkat cells, cDNA cloning, in vitro caspase cleavage assay, nuclei fragmentation assay","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 1 / Strong — purification, reconstitution of nuclease activity, in vitro caspase cleavage with functional readout; independently replicated across multiple labs","pmids":["9560346"],"is_preprint":false},{"year":1999,"finding":"DFF45 acts as both a molecular chaperone required for proper folding and expression of active DFF40, and as a direct inhibitor of DFF40 nuclease activity. Caspase-3 (but not caspase-6 or caspase-8) and caspase-7 cleave DFF45, causing dissociation of DFF45 fragments from DFF40 and allowing DFF40 to oligomerize into a large functional complex that cleaves DNA by introducing double-strand breaks. Histone H1 directly interacts with DFF40, confers DNA binding ability, stimulates nuclease activity by increasing Kcat and decreasing Km.","method":"In vitro reconstitution, caspase cleavage assays, co-immunoprecipitation, oligomerization assays, kinetic enzyme analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro with multiple orthogonal methods (binding, cleavage kinetics, oligomerization), replicated across labs","pmids":["10318789"],"is_preprint":false},{"year":1999,"finding":"DFFB (DFF40) contains a C-terminal catalytic domain (residues 290-345) and an N-terminal regulatory domain (residues 1-83). Deletion of the catalytic domain abolishes caspase-3-induced nuclease activity but not interaction with DFF45. Removal of the regulatory domain yields constitutively active DFF40 that neither binds DFF45 nor requires caspase-3 for activation. The N-terminal regulatory domain is homologous to the CIDE-N domain of DFF45/ICAD and CIDE proteins.","method":"Deletion mutagenesis, in vitro nuclease assays, co-immunoprecipitation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — systematic mutagenesis with functional nuclease assay and binding assay, multiple orthogonal readouts","pmids":["9867840"],"is_preprint":false},{"year":1999,"finding":"DFF45 interacts with DFF40 through three functional binding domains (D1, D2, D3): D1 binds the activator domain of DFF40, D2 binds the catalytic domain of DFF40. Inhibition of DFF40 nuclease activity arises independently from D1 sequestration of the activator domain and D2 blockage of the catalytic domain. Caspase cleavage of DFF45 disrupts the synergistic binding of its domains to DFF40, resulting in DFF40 activation.","method":"Domain deletion analysis, in vitro binding assays, nuclease activity assays","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain deletion with binding and activity assays, single lab, two orthogonal methods","pmids":["10527861","10527860"],"is_preprint":false},{"year":1999,"finding":"DFF35, an isoform of DFF45, cannot function as a chaperone for DFF40 (unlike DFF45), but binds DFF40 more strongly than DFF45 and inhibits its nuclease activity. The amino acid residues 101-180 of DFF35/45 mediate binding to DFF40, while residues 23-100 (homologous between DFF35/45 and DFF40) function to inhibit DFF40 activity.","method":"Deletion mutagenesis, functional nuclease assays, binding assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain mapping with binding and activity assays, single lab","pmids":["10409614"],"is_preprint":false},{"year":2000,"finding":"DFF40/CAD endonuclease has a pH optimum of 7.5, requires Mg2+ (not Ca2+), is inhibited by Zn2+, generates blunt ends or 1-base 5'-overhangs with 5'-phosphate and 3'-hydroxyl groups, is specific for double-stranded (not single-stranded) DNA, and attacks chromatin preferentially in the internucleosomal linker generating sharp oligonucleosomal DNA ladders. Histone H1, HMGB1, and topoisomerase II activate DFF endonuclease activity on naked DNA substrates.","method":"In vitro endonuclease assays with defined substrates, ion/cofactor titration, chromatin reconstitution","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — rigorous in vitro biochemical characterization with multiple substrates and conditions, replicated across labs","pmids":["10713148"],"is_preprint":false},{"year":2001,"finding":"DFF40/CAD nuclease activity requires K+ in the range of 50-125 mM (matching apoptotic cytoplasmic K+ concentrations) for optimal activity (~100-fold higher than at 0 or 200 mM K+); it requires Mg2+, is inhibited by Zn2+ and Cu2+, is active over pH 7.0-8.5, is thermally unstable (inactivated at 42°C), and at high ionic strengths introduces single-stranded nicks rather than double-strand breaks.","method":"In vitro endonuclease assays with defined ionic conditions","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — rigorous in vitro assay but single lab, single study","pmids":["11330826"],"is_preprint":false},{"year":2001,"finding":"CAD/DFF40 is essential for oligonucleosomal DNA fragmentation during apoptosis in chicken DT40 cells (CAD-/- cells fail to undergo oligonucleosomal fragmentation), but is dispensable for high molecular weight (HMW) DNA cleavage and early-stage (stage I) chromatin condensation. CAD is required for complete nuclear disassembly including final chromatin condensation and nuclear fragmentation.","method":"Gene knockout (CAD-/- DT40 cells), DNA fragmentation assays, apoptosis morphology analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined phenotypic readouts at multiple stages, ortholog study in avian model with clear loss-of-function","pmids":["11577114"],"is_preprint":false},{"year":2001,"finding":"The N-terminal domains (NTDs) of both DFF40 and DFF45 are homologous and interact with each other. The NTD of DFF45 alone is unstructured in solution, and its folding is induced upon binding to DFF40 NTD. The solution structure of the heterodimeric NTD complex reveals mutual chaperoning through an extensive intermolecular hydrophobic cluster surrounded by salt bridges.","method":"NMR solution structure determination, functional binding analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with functional validation, single lab but multiple orthogonal methods","pmids":["11371636"],"is_preprint":false},{"year":2004,"finding":"Crystal structure of activated CAD/DFF40 reveals it forms a dimer (molecular scissors) with a deep active-site crevice suited for distinguishing internucleosomal from nucleosomal DNA. ICAD/DFF45 sequesters the nonfunctional CAD/DFF40 monomer and can disassemble the functional CAD/DFF40 dimer through its middle domain; caspase cleavage of ICAD/DFF45 into three domains results in self-assembly of CAD/DFF40 into the active dimer.","method":"X-ray crystallography, functional binding and disassembly assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure combined with functional validation of activation mechanism, single highly rigorous study","pmids":["15149602"],"is_preprint":false},{"year":2005,"finding":"The histone H1 C-terminal domain (CTD) is responsible for activation of DFF40/CAD. The H1 CTD directly binds to DFF40/CAD and confers upon it an increased ability to bind DNA, thereby stimulating linker DNA cleavage. All six somatic cell histone H1 isoforms equally activate DFF40/CAD despite differing CTD primary sequences.","method":"Truncation mutagenesis of histone H1, direct binding assays, in vitro nuclease activity assays","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — truncation mutagenesis combined with binding and nuclease activity assays, multiple H1 isoforms tested","pmids":["15910001"],"is_preprint":false},{"year":2006,"finding":"HMGB1 stimulates DFF40/CAD-mediated DNA cleavage not by binding to DFF40/CAD or enhancing its DNA binding, but by inducing local DNA structural distortions through its HMG-box domains. A structural array of two HMG-boxes is required for stimulation. DNA strand cross-links (cisplatin/transplatin) mimicking HMG-box-induced distortions also affect DFF40/CAD cleavage, suggesting that DNA conformational changes induced by HMG-box binding increase substrate accessibility.","method":"In vitro nuclease assays with HMGB1 truncation mutants, DNA binding assays, cisplatin/transplatin cross-linking experiments","journal":"Acta biochimica Polonica","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple truncation constructs and chemical mimics tested, single lab","pmids":["18239742"],"is_preprint":false},{"year":2006,"finding":"Polyanions including RNA, single-stranded DNA, poly-glutamic acid, and heparin inhibit DFF40/CAD endonuclease by binding to the nuclease and impairing its ability to bind double-stranded DNA. Heparin is highly effective at nanomolar concentrations. The inhibitory poly-anions are proposed to bind the positively charged surface formed by alpha4 helices of the DFF40/CAD homodimer.","method":"In vitro nuclease competition assays, enzyme-inhibitor binding assays","journal":"Apoptosis : an international journal on programmed cell death","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple polyanion inhibitors tested with binding and activity assays, single lab","pmids":["16699957"],"is_preprint":false},{"year":2008,"finding":"DFF40/CAD is exclusively specific for double-stranded DNA; it does not cleave single-stranded DNA, single-stranded RNA, double-stranded RNA, or RNA-DNA heteroduplexes. Non-substrate oligonucleotides of all types competitively inhibit cleavage of double-stranded DNA. In vivo, activation of DFF40/CAD is not temporally correlated with total cellular or nuclear RNA degradation.","method":"In vitro nuclease assays with synthetic oligonucleotides of defined composition, in vivo apoptosis time-course analysis","journal":"Apoptosis : an international journal on programmed cell death","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — systematic substrate specificity analysis in vitro with multiple substrate types plus in vivo confirmation, single lab","pmids":["18283539"],"is_preprint":false},{"year":2009,"finding":"The C-terminal helix of DFF45 (residues 281-300) is dynamic and necessary for its chaperone activity toward DFF40 but not for inhibition of DFF40 nuclease activity, as determined by limited proteolysis showing residues 1-281 form a rigid domain while the C-terminal loop (residues 277-281) is trypsin-accessible.","method":"Limited proteolysis, crystallography, functional nuclease and chaperone assays","journal":"BMB reports","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — structural and biochemical analysis separating chaperone from inhibitory functions, single lab","pmids":["19944011"],"is_preprint":false},{"year":2010,"finding":"DFF40-DFF45 heterodimer localizes to the chromatin-enriched nuclear fraction under both apoptotic and non-apoptotic conditions in NB4 cells. DFF40 interacts with all H1 subtypes tested but preferentially associates with specific H1 subtypes following apoptosis induction by trichostatin A.","method":"Subcellular fractionation, MNase digestion, co-immunoprecipitation with histone H1 subtypes, apoptosis induction","journal":"Apoptosis : an international journal on programmed cell death","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — fractionation plus co-IP with functional context, single lab","pmids":["19882353"],"is_preprint":false},{"year":2012,"finding":"Oligonucleosomal DNA degradation by DFF40/CAD requires a cytosolic pool of the endonuclease. SK-N-AS neuroblastoma cells lacking cytosolic DFF40/CAD fail to undergo DNA laddering despite correct ICAD processing and caspase-3 activation; ICAD is preferentially processed in the cytosolic fraction, allowing DFF40/CAD to translocate from cytosol to chromatin-enriched fraction. Restoring cytosolic DFF40/CAD by overexpression rescues DNA laddering.","method":"Subcellular fractionation, overexpression rescue experiment, caspase activity assays, staurosporine-induced apoptosis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — fractionation, loss-of-function, and gain-of-function rescue with defined molecular readout, multiple orthogonal methods","pmids":["22253444"],"is_preprint":false},{"year":2016,"finding":"In human glioblastoma cells, DFF40/CAD is improperly accumulated in the nucleoplasmic subcellular compartment rather than the cytosol, impairing oligonucleosomal DNA fragmentation during apoptosis despite correct caspase activation. Overexpression of DFF40/CAD is sufficient to restore DNA laddering after apoptotic challenge in these cells.","method":"Subcellular fractionation, overexpression rescue, immunofluorescence, apoptosis assays in GBM cells","journal":"Neuro-oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — fractionation and overexpression rescue, single lab, consistent with prior findings in neuroblastoma","pmids":["26755073"],"is_preprint":false},{"year":2020,"finding":"DFFB is responsible for the first intracellular step of cell-free DNA fragmentation: analysis of cf.DNA ends in DFFB-deficient mice compared to wild-type mice establishes that DFFB generates the initial intracellular cuts in cf.DNA, with a specific cutting preference distinct from extracellular nucleases DNASE1L3 and DNASE1. The 10 bp periodicity in cf.DNA arises from cutting within intact nucleosomal structure.","method":"Nuclease-deficient mouse models, cell-free DNA end analysis, heparin disruption of nucleosomal structure","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo knockout mouse models with cf.DNA end sequencing, multiple nuclease comparisons, independent experimental validation","pmids":["32004449"],"is_preprint":false},{"year":2021,"finding":"DFF40 KO Jurkat T cells generated by CRISPR-Cas9 show chemoresistance to antimetabolites (methotrexate, 6-mercaptopurine, cytarabine) and increased sensitivity to topoisomerase II inhibitors (etoposide, teniposide). DFF40 deficiency impairs histone H2AX phosphorylation following etoposide and cytarabine treatments, suggesting DFF40 regulates genomic stability in the context of chemotherapy response.","method":"CRISPR-Cas9 knockout, cell viability assays, phospho-H2AX analysis, flow cytometry","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean CRISPR KO with multiple drug treatments and molecular readouts, single lab","pmids":["34678222"],"is_preprint":false},{"year":2022,"finding":"DFF40-deficient Jurkat cells exhibit higher mitochondrial mass, increased mtDNA copy number, elevated mitochondrial membrane potential, and higher glycolysis rates (Warburg effect phenotype), with higher Mcl-1 at basal state and resistance to staurosporine- and TBT-induced apoptosis. Cell fractionation shows DFF40 can translocate to the mitochondria following apoptosis induction, suggesting a role in regulating mitochondrial function during cell death.","method":"CRISPR-Cas9 KO, cell fractionation, mitochondrial function assays, metabolic profiling","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO with multiple metabolic readouts and fractionation, single lab","pmids":["35460011"],"is_preprint":false},{"year":2022,"finding":"The CIDE domain of DFF40 (and its fly orthologue DREP4) forms filament-like assemblies critical for nuclease function. DREP4 CIDE specifically binds histones H1 and H2, an interaction important for nuclease activity.","method":"Structural study, CIDE domain filament characterization, histone binding assays, nuclease activity assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — structural and biochemical analysis with ortholog, single lab","pmids":["35236824"],"is_preprint":false},{"year":2006,"finding":"DFF40-immunopositive proteins in intact rat liver exist primarily as a 52 kDa form. During hepatic ischemia/reperfusion, caspase-3 activation results in time-dependent accumulation of DFF40-positive fragments (40 and 20 kDa). Immunoprecipitation reveals active caspase-3 is present in the DFF40-immunopositive 20 kDa fraction, suggesting physical association of active caspase-3 with DFF40 cleavage products. Chronic alcohol administration produces similar DFF40 fragmentation.","method":"In vivo rat liver injury models, Western blotting, in vitro recombinant caspase-3 digestion, immunoprecipitation","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo model plus in vitro reconstitution with caspase-3, immunoprecipitation, single lab","pmids":["17011520"],"is_preprint":false},{"year":2025,"finding":"In cancer persister cells surviving oncogene-targeted therapy, DFFB (CAD/DFF40) is sublethal activated by apoptotic caspases, induces DNA damage, mutagenesis, and upregulates ATF3. ATF3 then limits AP1-mediated interferon-stimulated gene (ISG) expression, suppressing Type I IFN signaling and enabling persister cell regrowth. DFFB-deficient persister cells exhibit high ISG expression and are unable to regrow.","method":"DFFB-deficient cell lines, ISG expression analysis, ATF3 perturbation, caspase activity assays, DNA damage assays","journal":"bioRxiv : the preprint server for biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function and pathway placement with multiple molecular readouts, preprint not yet peer-reviewed","pmids":["40894800"],"is_preprint":true}],"current_model":"DFFB (DFF40/CAD) is a Mg2+-dependent, double-strand-specific endonuclease that exists in an inactive heterodimeric complex with its chaperone/inhibitor DFF45 (ICAD) in the cytosol; upon apoptotic activation of caspase-3 or -7, DFF45 is cleaved and releases DFF40, which self-assembles into an active dimer (molecular scissors, as revealed by crystal structure) that translocates from cytosol to chromatin and cleaves internucleosomal linker DNA to produce oligonucleosomal ladders. Its activity is further regulated by histone H1 (which binds the enzyme, increases DNA-binding ability, and stimulates cleavage via the H1 C-terminal domain), HMGB1/2, topoisomerase II, and polyanion inhibitors, and in vivo it performs the first intracellular step of cell-free DNA fragmentation. Beyond canonical apoptosis, sublethal caspase-mediated DFFB activation in cancer persister cells induces DNA damage and ATF3 upregulation that suppresses interferon signaling to enable persister cell regrowth, and loss of DFF40 alters mitochondrial metabolism and chemotherapy sensitivity."},"narrative":{"mechanistic_narrative":"DFFB (DFF40/CAD) is the caspase-activated, Mg2+-dependent endonuclease that executes apoptotic internucleosomal DNA fragmentation, cleaving chromatin in the linker between nucleosomes to generate the characteristic oligonucleosomal DNA ladder [PMID:9560346, PMID:10713148, PMID:11577114]. In healthy cells it is held inactive as a heterodimer with DFF45/ICAD, which serves dual roles as a folding chaperone required for the expression of active DFF40 and as a direct steric inhibitor that sequesters the nuclease; caspase-3 and caspase-7 cleave DFF45, releasing fragments and permitting DFF40 to self-assemble into the active enzyme [PMID:9560346, PMID:10318789, PMID:19944011]. DFF40 is organized into an N-terminal CIDE-N regulatory domain that mediates DFF45 binding and a C-terminal catalytic domain; its NTD and the DFF45 NTD fold into each other through mutual chaperoning, and the activated enzyme forms a dimeric \"molecular scissors\" whose deep active-site crevice discriminates internucleosomal from nucleosomal DNA [PMID:9867840, PMID:11371636, PMID:15149602]. The CIDE domain forms filament-like assemblies required for nuclease function [PMID:35236824]. Catalytically the enzyme is strictly double-strand-DNA specific, requires Mg2+ and physiological K+, is inhibited by Zn2+, and produces blunt or short 5'-overhang ends bearing 5'-phosphate and 3'-hydroxyl groups [PMID:10713148, PMID:11330826, PMID:18283539]. Its activity is positively modulated by chromatin and architectural factors — histone H1 binds DFF40 (via its C-terminal domain) to confer DNA-binding ability and increase catalytic efficiency, HMGB1 stimulates cleavage by distorting DNA structure, and polyanions such as heparin and RNA act as inhibitors [PMID:10318789, PMID:15910001, PMID:18239742, PMID:16699957]. Efficient fragmentation depends on a cytosolic pool of DFF40 that, upon cytosolic ICAD processing, translocates to chromatin; mislocalization to the nucleoplasm in tumor cells impairs DNA laddering despite intact caspase activation [PMID:22253444, PMID:26755073]. In vivo DFFB performs the first intracellular step of cell-free DNA fragmentation, generating the initial nucleosome-patterned cuts [PMID:32004449]. Beyond canonical apoptosis, DFF40 loss alters mitochondrial mass, metabolism, and chemotherapy sensitivity [PMID:34678222, PMID:35460011], and sublethal caspase-mediated DFFB activation in cancer persister cells drives DNA damage and ATF3 upregulation that suppresses interferon signaling to enable regrowth [PMID:40894800].","teleology":[{"year":1998,"claim":"Established the existence and core logic of DFFB as a caspase-activated nuclease controlled by an inhibitory partner, answering how apoptotic DNA fragmentation is triggered downstream of caspases.","evidence":"Protein purification from Jurkat cells, cDNA cloning, in vitro caspase cleavage and nuclei fragmentation assays","pmids":["9560346"],"confidence":"High","gaps":["Did not resolve the molecular mechanism of inhibition or the structure of the active enzyme","Identity of the activating caspases not fully defined"]},{"year":1999,"claim":"Defined DFF45 as both chaperone and direct inhibitor, identified caspase-3/-7 (not -6/-8) as the activating proteases, and showed DFF40 oligomerizes to introduce double-strand breaks, with histone H1 as a positive cofactor.","evidence":"In vitro reconstitution, caspase cleavage, co-IP, oligomerization and kinetic assays","pmids":["10318789"],"confidence":"High","gaps":["Structural basis of oligomerization unresolved","Mechanism by which H1 stimulates activity not mapped"]},{"year":1999,"claim":"Mapped the domain architecture of DFF40 (C-terminal catalytic, N-terminal regulatory/CIDE-N) and the multi-domain binding/inhibition mechanism of DFF45, explaining how caspase cleavage relieves inhibition.","evidence":"Deletion mutagenesis, in vitro nuclease and binding assays (DFF40 domains; DFF45 D1/D2/D3 domains)","pmids":["9867840","10527861","10527860"],"confidence":"High","gaps":["Atomic-resolution structure of the heterodimer not yet available","How constitutive activity is restrained in vivo unclear"]},{"year":1999,"claim":"Showed the DFF45 isoform DFF35 inhibits but cannot chaperone DFF40, dissociating the chaperone and inhibitory functions and localizing them to distinct sequence regions.","evidence":"Deletion mutagenesis, nuclease and binding assays","pmids":["10409614"],"confidence":"Medium","gaps":["Physiological role of DFF35 versus DFF45 in cells not established","Single-lab domain mapping"]},{"year":2000,"claim":"Provided rigorous biochemical definition of catalytic requirements (Mg2+, pH, dsDNA specificity, internucleosomal preference, end chemistry) and cofactor activation by H1, HMGB1, and topoisomerase II.","evidence":"In vitro endonuclease assays with defined substrates and cofactors, chromatin reconstitution","pmids":["10713148"],"confidence":"High","gaps":["In vivo relevance of individual cofactors not dissected","Structural basis of linker-DNA preference not yet shown"]},{"year":2001,"claim":"Defined the ionic environment for activity, showing K+ in the apoptotic physiological range optimizes activity and ionic strength governs single- versus double-strand cutting.","evidence":"In vitro endonuclease assays under varied ionic conditions","pmids":["11330826"],"confidence":"Medium","gaps":["Single study, single lab","In vivo confirmation of K+ dependence absent"]},{"year":2001,"claim":"Genetically established that CAD/DFF40 is required specifically for oligonucleosomal fragmentation and final nuclear disassembly but dispensable for HMW cleavage and early chromatin condensation.","evidence":"CAD-/- DT40 chicken knockout cells, DNA fragmentation and apoptotic morphology analysis","pmids":["11577114"],"confidence":"High","gaps":["Identity of nucleases responsible for HMW cleavage not addressed","Avian model; mammalian in vivo requirement shown later"]},{"year":2001,"claim":"Solved the solution structure of the DFF40/DFF45 NTD complex, revealing mutual chaperoning via coupled folding and an intermolecular hydrophobic core.","evidence":"NMR solution structure of heterodimeric NTDs with binding analysis","pmids":["11371636"],"confidence":"High","gaps":["Structure of the full catalytic domain not resolved here","Does not show the active dimer conformation"]},{"year":2004,"claim":"Crystal structure of activated CAD revealed the dimeric 'molecular scissors' architecture and explained how ICAD sequesters monomer and disassembles the dimer, completing the activation mechanism.","evidence":"X-ray crystallography with functional binding and disassembly assays","pmids":["15149602"],"confidence":"High","gaps":["Structure of enzyme bound to DNA/nucleosome not determined","Filament-level assembly not captured"]},{"year":2005,"claim":"Identified the histone H1 C-terminal domain as the activating element that binds DFF40 and enhances its DNA binding, mechanistically explaining chromatin-dependent stimulation.","evidence":"H1 truncation mutagenesis, binding and nuclease assays across H1 isoforms","pmids":["15910001"],"confidence":"High","gaps":["Structural basis of the H1 CTD–DFF40 interaction unresolved","Why isoforms are functionally equivalent despite sequence divergence unexplained"]},{"year":2006,"claim":"Distinguished cofactor mechanisms: HMGB1 stimulates cleavage by distorting DNA structure rather than binding the enzyme, while polyanions inhibit by blocking DFF40 DNA binding.","evidence":"In vitro nuclease assays with HMGB1 and polyanion truncations/mimics, binding assays","pmids":["18239742","16699957"],"confidence":"Medium","gaps":["Physiological concentrations and relevance of polyanion inhibition in cells unclear","Single-lab studies"]},{"year":2008,"claim":"Confirmed strict double-stranded DNA substrate specificity and showed non-substrate nucleic acids act as competitive inhibitors, ruling out RNA degradation as a DFF40 function.","evidence":"In vitro assays with defined oligonucleotides plus in vivo apoptosis time-course","pmids":["18283539"],"confidence":"Medium","gaps":["Single lab","Competitive inhibition relevance in vivo not quantified"]},{"year":2009,"claim":"Separated DFF45 chaperone activity (requiring its dynamic C-terminal helix) from its inhibitory activity, refining the structural basis of the two ICAD functions.","evidence":"Limited proteolysis, crystallography, chaperone and nuclease assays","pmids":["19944011"],"confidence":"Medium","gaps":["In vivo consequence of selectively disabling chaperone function not tested","Single lab"]},{"year":2010,"claim":"Demonstrated chromatin-associated localization of the DFF40–DFF45 heterodimer and preferential H1-subtype association upon apoptosis, linking biochemistry to subnuclear positioning.","evidence":"Subcellular fractionation, MNase digestion, co-IP with H1 subtypes in NB4 cells","pmids":["19882353"],"confidence":"Medium","gaps":["Functional consequence of subtype preference unclear","Single cell line"]},{"year":2016,"claim":"Established that a cytosolic pool of DFF40 and its proper cytosol-to-chromatin translocation are required for laddering; mislocalization (nucleoplasmic accumulation) impairs fragmentation despite intact caspase signaling.","evidence":"Subcellular fractionation, loss- and gain-of-function rescue in neuroblastoma and glioblastoma cells","pmids":["22253444","26755073"],"confidence":"High","gaps":["Molecular machinery controlling translocation unidentified","Why tumor cells mislocalize DFF40 unknown"]},{"year":2020,"claim":"Showed in vivo that DFFB executes the first intracellular cut in cell-free DNA with a distinct, nucleosome-patterned cutting preference, defining its role in cf.DNA biogenesis.","evidence":"DFFB-deficient mouse models with cf.DNA end sequencing and nuclease comparisons","pmids":["32004449"],"confidence":"High","gaps":["Relationship between intracellular DFFB cuts and downstream extracellular processing only partly resolved","Tissue sources of cf.DNA not fully dissected"]},{"year":2022,"claim":"Revealed non-apoptotic and structural roles: CIDE-domain filament assembly is required for nuclease function, and DFF40 loss reprograms mitochondrial mass and metabolism while DFF40 can translocate to mitochondria during cell death.","evidence":"CIDE filament structural study with histone binding (DREP4 ortholog); CRISPR KO Jurkat cells with metabolic profiling and fractionation","pmids":["35236824","35460011"],"confidence":"Medium","gaps":["Mechanism linking DFF40 to mitochondrial metabolism unknown","Functional role of mitochondrial DFF40 undefined"]},{"year":2021,"claim":"Linked DFF40 to chemotherapy response and genomic stability, with KO cells showing differential drug sensitivity and impaired H2AX phosphorylation.","evidence":"CRISPR-Cas9 KO Jurkat cells, viability assays, phospho-H2AX analysis","pmids":["34678222"],"confidence":"Medium","gaps":["Mechanism of impaired DNA damage signaling unclear","Single cell type"]},{"year":2025,"claim":"Implicated sublethal DFFB activation in cancer persistence, where caspase-driven DNA damage and ATF3 upregulation suppress interferon signaling to permit persister regrowth.","evidence":"DFFB-deficient cell lines, ISG and ATF3 perturbation, caspase and DNA damage assays (preprint)","pmids":["40894800"],"confidence":"Medium","gaps":["Preprint, not yet peer-reviewed","Direct molecular link from DFFB activity to ATF3 induction not fully resolved","Generality across tumor types untested"]},{"year":null,"claim":"How DFF40's cytosol-to-chromatin (and mitochondrial) translocation is controlled, and the structural basis of its engagement with nucleosomal substrate, remain open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structure of DFF40 bound to nucleosomal/linker DNA","Trafficking machinery for translocation unidentified","Mechanistic basis of non-apoptotic metabolic and persister phenotypes incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[0,1,5,7,13]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,5,6]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[5,10,12,13]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[16,17]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[5,7,15,16]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[17]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[20]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,1,7,16]}],"complexes":["DFF40–DFF45 (CAD–ICAD) heterodimer"],"partners":["DFFA","HIST1H1 (HISTONE H1)","HMGB1","CASP3","CASP7","TOP2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O76075","full_name":"DNA fragmentation factor subunit beta","aliases":["Caspase-activated deoxyribonuclease","CAD","Caspase-activated DNase","Caspase-activated nuclease","CPAN","DNA fragmentation factor 40 kDa subunit","DFF-40"],"length_aa":338,"mass_kda":39.1,"function":"Nuclease that induces DNA fragmentation and chromatin condensation during apoptosis. Degrades naked DNA and induces apoptotic morphology","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/O76075/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DFFB","classification":"Not Classified","n_dependent_lines":28,"n_total_lines":1208,"dependency_fraction":0.023178807947019868},"opencell":{"profiled":true,"resolved_as":"CAD","ensg_id":"ENSG00000084774","cell_line_id":"CID000996","localizations":[{"compartment":"cytoplasmic","grade":3}],"interactors":[{"gene":"MRTO4","stoichiometry":10.0},{"gene":"CDC37","stoichiometry":0.2},{"gene":"CAPZB","stoichiometry":0.2},{"gene":"FKBP5","stoichiometry":0.2},{"gene":"HMGN5","stoichiometry":0.2},{"gene":"MIF","stoichiometry":0.2},{"gene":"PTGES3","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000996","total_profiled":1310},"omim":[{"mim_id":"619858","title":"AUTOINFLAMMATORY-PANCYTOPENIA SYNDROME; AIPCS","url":"https://www.omim.org/entry/619858"},{"mim_id":"610177","title":"APOPTOSIS-ENHANCING NUCLEASE; AEN","url":"https://www.omim.org/entry/610177"},{"mim_id":"604440","title":"CELL DEATH-INDUCING DFFA-LIKE EFFECTOR A; CIDEA","url":"https://www.omim.org/entry/604440"},{"mim_id":"601883","title":"DNA FRAGMENTATION FACTOR, 40-KD, BETA SUBUNIT; DFFB","url":"https://www.omim.org/entry/601883"},{"mim_id":"601882","title":"DNA FRAGMENTATION FACTOR, 45-KD, ALPHA SUBUNIT; DFFA","url":"https://www.omim.org/entry/601882"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoli","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DFFB"},"hgnc":{"alias_symbol":["CAD","CPAN","DFF-40","DFF40"],"prev_symbol":[]},"alphafold":{"accession":"O76075","domains":[{"cath_id":"3.10.20.10","chopping":"7-84","consensus_level":"high","plddt":93.8833,"start":7,"end":84},{"cath_id":"-","chopping":"153-307","consensus_level":"high","plddt":95.2195,"start":153,"end":307},{"cath_id":"1.10.287","chopping":"96-128","consensus_level":"high","plddt":91.8948,"start":96,"end":128}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O76075","model_url":"https://alphafold.ebi.ac.uk/files/AF-O76075-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O76075-F1-predicted_aligned_error_v6.png","plddt_mean":92.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DFFB","jax_strain_url":"https://www.jax.org/strain/search?query=DFFB"},"sequence":{"accession":"O76075","fasta_url":"https://rest.uniprot.org/uniprotkb/O76075.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O76075/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O76075"}},"corpus_meta":[{"pmid":"32004449","id":"PMC_32004449","title":"The Biology of Cell-free DNA Fragmentation and the Roles of DNASE1, DNASE1L3, and DFFB.","date":"2020","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32004449","citation_count":197,"is_preprint":false},{"pmid":"9560346","id":"PMC_9560346","title":"CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45.","date":"1998","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/9560346","citation_count":190,"is_preprint":false},{"pmid":"15723341","id":"PMC_15723341","title":"Discovery, regulation, and action of the major apoptotic nucleases DFF40/CAD and endonuclease G.","date":"2005","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15723341","citation_count":166,"is_preprint":false},{"pmid":"10318789","id":"PMC_10318789","title":"Activation of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease). Oligomerization and direct interaction with histone H1.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10318789","citation_count":161,"is_preprint":false},{"pmid":"10713148","id":"PMC_10713148","title":"Cleavage preferences of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease) on naked DNA and chromatin substrates.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10713148","citation_count":139,"is_preprint":false},{"pmid":"15149602","id":"PMC_15149602","title":"Structural mechanism for inactivation and activation of CAD/DFF40 in the apoptotic pathway.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15149602","citation_count":90,"is_preprint":false},{"pmid":"11577114","id":"PMC_11577114","title":"CAD/DFF40 nuclease is dispensable for high molecular weight DNA cleavage and stage I chromatin condensation in apoptosis.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11577114","citation_count":87,"is_preprint":false},{"pmid":"11996094","id":"PMC_11996094","title":"The DFF40/CAD endonuclease and its role in apoptosis.","date":"2000","source":"Acta biochimica Polonica","url":"https://pubmed.ncbi.nlm.nih.gov/11996094","citation_count":82,"is_preprint":false},{"pmid":"11371636","id":"PMC_11371636","title":"Solution structure of DFF40 and DFF45 N-terminal domain complex and mutual chaperone activity of DFF40 and DFF45.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11371636","citation_count":77,"is_preprint":false},{"pmid":"10409614","id":"PMC_10409614","title":"Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10409614","citation_count":75,"is_preprint":false},{"pmid":"9867840","id":"PMC_9867840","title":"Identification of regulatory and catalytic domains in the apoptosis nuclease DFF40/CAD.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9867840","citation_count":66,"is_preprint":false},{"pmid":"15910001","id":"PMC_15910001","title":"The histone H1 C-terminal domain binds to the apoptotic nuclease, DNA fragmentation factor (DFF40/CAD) and stimulates DNA cleavage.","date":"2005","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15910001","citation_count":56,"is_preprint":false},{"pmid":"11577712","id":"PMC_11577712","title":"Apoptosis induction by T-2 toxin: activation of caspase-9, caspase-3, and DFF-40/CAD through cytosolic release of cytochrome c in HL-60 cells.","date":"2001","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11577712","citation_count":49,"is_preprint":false},{"pmid":"11330826","id":"PMC_11330826","title":"Ionic and cofactor requirements for the activity of the apoptotic endonuclease DFF40/CAD.","date":"2001","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11330826","citation_count":42,"is_preprint":false},{"pmid":"10527861","id":"PMC_10527861","title":"Multiple domains of DFF45 bind synergistically to DFF40: roles of caspase cleavage and sequestration of activator domain of DFF40.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10527861","citation_count":34,"is_preprint":false},{"pmid":"10527860","id":"PMC_10527860","title":"Study of DFF45 in its role of chaperone and inhibitor: two independent inhibitory domains of DFF40 nuclease activity.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10527860","citation_count":30,"is_preprint":false},{"pmid":"28104392","id":"PMC_28104392","title":"Scutellarein antagonizes the tumorigenesis by modulating cytokine VEGF mediated neoangiogenesis and DFF-40 actuated nucleosomal degradation.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28104392","citation_count":28,"is_preprint":false},{"pmid":"11960352","id":"PMC_11960352","title":"T and B leukemic cell lines exhibit different requirements for cell death: correlation between caspase activation, DFF40/DFF45 expression, DNA fragmentation and apoptosis in T cell lines but not in Burkitt's lymphoma.","date":"2002","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/11960352","citation_count":27,"is_preprint":false},{"pmid":"22253444","id":"PMC_22253444","title":"Apoptotic DNA degradation into oligonucleosomal fragments, but not apoptotic nuclear morphology, relies on a cytosolic pool of DFF40/CAD endonuclease.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22253444","citation_count":25,"is_preprint":false},{"pmid":"26755073","id":"PMC_26755073","title":"An intrinsic DFF40/CAD endonuclease deficiency impairs oligonucleosomal DNA hydrolysis during caspase-dependent cell death: a common trait in human glioblastoma cells.","date":"2016","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/26755073","citation_count":20,"is_preprint":false},{"pmid":"23529188","id":"PMC_23529188","title":"GM-CSF-DFF40: a novel humanized immunotoxin induces apoptosis in acute myeloid leukemia cells.","date":"2013","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/23529188","citation_count":19,"is_preprint":false},{"pmid":"24587967","id":"PMC_24587967","title":"Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer.","date":"2013","source":"Journal of genetic syndromes & gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/24587967","citation_count":19,"is_preprint":false},{"pmid":"18283539","id":"PMC_18283539","title":"The major apoptotic endonuclease DFF40/CAD is a deoxyribose-specific and double-strand-specific enzyme.","date":"2008","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/18283539","citation_count":18,"is_preprint":false},{"pmid":"16936813","id":"PMC_16936813","title":"Unique features of the apoptotic endonuclease DFF40/CAD relative to micrococcal nuclease as a structural probe for chromatin.","date":"2006","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/16936813","citation_count":18,"is_preprint":false},{"pmid":"29075126","id":"PMC_29075126","title":"DNA fragmentation factors 40 and 45 (DFF40/DFF45) and B-cell lymphoma 2 (Bcl-2) protein are underexpressed in uterine leiomyosarcomas and may predict survival.","date":"2017","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29075126","citation_count":17,"is_preprint":false},{"pmid":"15946692","id":"PMC_15946692","title":"Sulindac activates nuclear translocation of AIF, DFF40 and endonuclease G but not induces oligonucleosomal DNA fragmentation in HT-29 cells.","date":"2005","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/15946692","citation_count":17,"is_preprint":false},{"pmid":"16156899","id":"PMC_16156899","title":"Attenuated expression of DFFB is a hallmark of oligodendrogliomas with 1p-allelic loss.","date":"2005","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16156899","citation_count":16,"is_preprint":false},{"pmid":"16699957","id":"PMC_16699957","title":"The apoptotic endonuclease DFF40/CAD is inhibited by RNA, heparin and other polyanions.","date":"2006","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/16699957","citation_count":16,"is_preprint":false},{"pmid":"26529233","id":"PMC_26529233","title":"Sensitization of breast cancer cells to doxorubicin via stable cell line generation and overexpression of DFF40.","date":"2015","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/26529233","citation_count":13,"is_preprint":false},{"pmid":"29524520","id":"PMC_29524520","title":"The tumor antagonistic steroidal alkaloid Solanidine prompts the intrinsic suicidal signal mediated DFF-40 nuclear import and nucleosomal disruption.","date":"2018","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29524520","citation_count":13,"is_preprint":false},{"pmid":"18239742","id":"PMC_18239742","title":"High mobility group proteins stimulate DNA cleavage by apoptotic endonuclease DFF40/CAD due to HMG-box interactions with DNA.","date":"2008","source":"Acta biochimica Polonica","url":"https://pubmed.ncbi.nlm.nih.gov/18239742","citation_count":12,"is_preprint":false},{"pmid":"33387146","id":"PMC_33387146","title":"The role of the DFF40/CAD endonuclease in genomic stability.","date":"2021","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/33387146","citation_count":10,"is_preprint":false},{"pmid":"19882353","id":"PMC_19882353","title":"Histone H1 subtype preferences of DFF40 and possible nuclear localization of DFF40/45 in normal and trichostatin A-treated NB4 leukemic cells.","date":"2010","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/19882353","citation_count":9,"is_preprint":false},{"pmid":"28914671","id":"PMC_28914671","title":"Endometrial Polyps and Benign Endometrial Hyperplasia Have Increased Prevalence of DNA Fragmentation Factors 40 and 45 (DFF40 and DFF45) Together With the Antiapoptotic B-Cell Lymphoma (Bcl-2) Protein Compared With Normal Human Endometria.","date":"2018","source":"International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists","url":"https://pubmed.ncbi.nlm.nih.gov/28914671","citation_count":9,"is_preprint":false},{"pmid":"19944011","id":"PMC_19944011","title":"Fifty C-terminal amino acid residues are necessary for the chaperone activity of DFF45 but not for the inhibition of DFF40.","date":"2009","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/19944011","citation_count":9,"is_preprint":false},{"pmid":"25045589","id":"PMC_25045589","title":"Safeguarding Stem Cell-Based Regenerative Therapy against Iatrogenic Cancerogenesis: Transgenic Expression of DNASE1, DNASE1L3, DNASE2, DFFB Controlled By POLA1 Promoter in Proliferating and Directed Differentiation Resisting Human Autologous Pluripotent Induced Stem Cells Leads to their Death.","date":"2013","source":"Journal of stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25045589","citation_count":8,"is_preprint":false},{"pmid":"34482510","id":"PMC_34482510","title":"DFF40-iRGD, a novel chimeric protein with efficient cytotoxic and apoptotic effects against triple-negative breast cancer cells.","date":"2021","source":"Biotechnology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34482510","citation_count":7,"is_preprint":false},{"pmid":"34678222","id":"PMC_34678222","title":"DFF40 deficiency in cancerous T cells is implicated in chemotherapy drug sensitivity and resistance through the regulation of the apoptotic pathway.","date":"2021","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34678222","citation_count":6,"is_preprint":false},{"pmid":"35236824","id":"PMC_35236824","title":"Molecular basis of apoptotic DNA fragmentation by DFF40.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35236824","citation_count":5,"is_preprint":false},{"pmid":"33177874","id":"PMC_33177874","title":"HNRNPCL1, PRAMEF1, CFAP74, and DFFB: Common Potential Biomarkers for Sporadic and Suspected Lynch Syndrome Endometrial Cancer.","date":"2020","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/33177874","citation_count":5,"is_preprint":false},{"pmid":"37215747","id":"PMC_37215747","title":"MEG3 Regulates CSE-Induced Apoptosis by Regulating miR-421/DFFB Signal Axis.","date":"2023","source":"International journal of chronic obstructive pulmonary disease","url":"https://pubmed.ncbi.nlm.nih.gov/37215747","citation_count":5,"is_preprint":false},{"pmid":"36819185","id":"PMC_36819185","title":"Malignant DFFB isoform switching promotes leukemia survival in relapse pediatric T-cell acute lymphoblastic leukemia.","date":"2022","source":"EJHaem","url":"https://pubmed.ncbi.nlm.nih.gov/36819185","citation_count":4,"is_preprint":false},{"pmid":"34771741","id":"PMC_34771741","title":"Gossypol Treatment Restores Insufficient Apoptotic Function of DFF40/CAD in Human Glioblastoma Cells.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34771741","citation_count":4,"is_preprint":false},{"pmid":"23156675","id":"PMC_23156675","title":"[Repressional effects of the glutamate antibodies on expression of Dffb gene in the brain of rats with experimental Alzheimer's disease].","date":"2012","source":"Molekuliarnaia biologiia","url":"https://pubmed.ncbi.nlm.nih.gov/23156675","citation_count":3,"is_preprint":false},{"pmid":"31592077","id":"PMC_31592077","title":"Two Simple Methods for Optimizing the Production of \"Difficult-to-Express\" GnRH-DFF40 Chimeric Protein.","date":"2019","source":"Advanced pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/31592077","citation_count":2,"is_preprint":false},{"pmid":"35460011","id":"PMC_35460011","title":"Energetic metabolic reprogramming in Jurkat DFF40-deficient cancer cells.","date":"2022","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35460011","citation_count":1,"is_preprint":false},{"pmid":"40894800","id":"PMC_40894800","title":"DFFB suppresses interferon to enable cancer persister cell regrowth.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40894800","citation_count":1,"is_preprint":false},{"pmid":"17011520","id":"PMC_17011520","title":"Generation of aberrant forms of DFF40 concurrent with caspase-3 activation during acute and chronic liver injury in rats.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17011520","citation_count":1,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.08.28.24312755","title":"cfGWAS reveal genetic basis of cell-free DNA features","date":"2024-08-30","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.28.24312755","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":25217,"output_tokens":6280,"usd":0.084926,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15039,"output_tokens":5617,"usd":0.10781,"stage2_stop_reason":"end_turn"},"total_usd":0.192736,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"DFFB (CPAN/DFF40) is a caspase-activated 40 kDa endonuclease sufficient to degrade naked DNA and induce apoptotic morphology and DNA fragmentation in naive nuclei. Its activity is regulated by DFF45, which is required for CPAN expression and stabilization in an inactive state; proteolytic cleavage of DFF45 by caspases leads to dissociation of DFF45 fragments from CPAN and activation of CPAN endonuclease activity.\",\n      \"method\": \"Protein purification from Jurkat cells, cDNA cloning, in vitro caspase cleavage assay, nuclei fragmentation assay\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — purification, reconstitution of nuclease activity, in vitro caspase cleavage with functional readout; independently replicated across multiple labs\",\n      \"pmids\": [\"9560346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"DFF45 acts as both a molecular chaperone required for proper folding and expression of active DFF40, and as a direct inhibitor of DFF40 nuclease activity. Caspase-3 (but not caspase-6 or caspase-8) and caspase-7 cleave DFF45, causing dissociation of DFF45 fragments from DFF40 and allowing DFF40 to oligomerize into a large functional complex that cleaves DNA by introducing double-strand breaks. Histone H1 directly interacts with DFF40, confers DNA binding ability, stimulates nuclease activity by increasing Kcat and decreasing Km.\",\n      \"method\": \"In vitro reconstitution, caspase cleavage assays, co-immunoprecipitation, oligomerization assays, kinetic enzyme analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro with multiple orthogonal methods (binding, cleavage kinetics, oligomerization), replicated across labs\",\n      \"pmids\": [\"10318789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"DFFB (DFF40) contains a C-terminal catalytic domain (residues 290-345) and an N-terminal regulatory domain (residues 1-83). Deletion of the catalytic domain abolishes caspase-3-induced nuclease activity but not interaction with DFF45. Removal of the regulatory domain yields constitutively active DFF40 that neither binds DFF45 nor requires caspase-3 for activation. The N-terminal regulatory domain is homologous to the CIDE-N domain of DFF45/ICAD and CIDE proteins.\",\n      \"method\": \"Deletion mutagenesis, in vitro nuclease assays, co-immunoprecipitation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — systematic mutagenesis with functional nuclease assay and binding assay, multiple orthogonal readouts\",\n      \"pmids\": [\"9867840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"DFF45 interacts with DFF40 through three functional binding domains (D1, D2, D3): D1 binds the activator domain of DFF40, D2 binds the catalytic domain of DFF40. Inhibition of DFF40 nuclease activity arises independently from D1 sequestration of the activator domain and D2 blockage of the catalytic domain. Caspase cleavage of DFF45 disrupts the synergistic binding of its domains to DFF40, resulting in DFF40 activation.\",\n      \"method\": \"Domain deletion analysis, in vitro binding assays, nuclease activity assays\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain deletion with binding and activity assays, single lab, two orthogonal methods\",\n      \"pmids\": [\"10527861\", \"10527860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"DFF35, an isoform of DFF45, cannot function as a chaperone for DFF40 (unlike DFF45), but binds DFF40 more strongly than DFF45 and inhibits its nuclease activity. The amino acid residues 101-180 of DFF35/45 mediate binding to DFF40, while residues 23-100 (homologous between DFF35/45 and DFF40) function to inhibit DFF40 activity.\",\n      \"method\": \"Deletion mutagenesis, functional nuclease assays, binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain mapping with binding and activity assays, single lab\",\n      \"pmids\": [\"10409614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"DFF40/CAD endonuclease has a pH optimum of 7.5, requires Mg2+ (not Ca2+), is inhibited by Zn2+, generates blunt ends or 1-base 5'-overhangs with 5'-phosphate and 3'-hydroxyl groups, is specific for double-stranded (not single-stranded) DNA, and attacks chromatin preferentially in the internucleosomal linker generating sharp oligonucleosomal DNA ladders. Histone H1, HMGB1, and topoisomerase II activate DFF endonuclease activity on naked DNA substrates.\",\n      \"method\": \"In vitro endonuclease assays with defined substrates, ion/cofactor titration, chromatin reconstitution\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — rigorous in vitro biochemical characterization with multiple substrates and conditions, replicated across labs\",\n      \"pmids\": [\"10713148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"DFF40/CAD nuclease activity requires K+ in the range of 50-125 mM (matching apoptotic cytoplasmic K+ concentrations) for optimal activity (~100-fold higher than at 0 or 200 mM K+); it requires Mg2+, is inhibited by Zn2+ and Cu2+, is active over pH 7.0-8.5, is thermally unstable (inactivated at 42°C), and at high ionic strengths introduces single-stranded nicks rather than double-strand breaks.\",\n      \"method\": \"In vitro endonuclease assays with defined ionic conditions\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — rigorous in vitro assay but single lab, single study\",\n      \"pmids\": [\"11330826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CAD/DFF40 is essential for oligonucleosomal DNA fragmentation during apoptosis in chicken DT40 cells (CAD-/- cells fail to undergo oligonucleosomal fragmentation), but is dispensable for high molecular weight (HMW) DNA cleavage and early-stage (stage I) chromatin condensation. CAD is required for complete nuclear disassembly including final chromatin condensation and nuclear fragmentation.\",\n      \"method\": \"Gene knockout (CAD-/- DT40 cells), DNA fragmentation assays, apoptosis morphology analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined phenotypic readouts at multiple stages, ortholog study in avian model with clear loss-of-function\",\n      \"pmids\": [\"11577114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The N-terminal domains (NTDs) of both DFF40 and DFF45 are homologous and interact with each other. The NTD of DFF45 alone is unstructured in solution, and its folding is induced upon binding to DFF40 NTD. The solution structure of the heterodimeric NTD complex reveals mutual chaperoning through an extensive intermolecular hydrophobic cluster surrounded by salt bridges.\",\n      \"method\": \"NMR solution structure determination, functional binding analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with functional validation, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"11371636\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Crystal structure of activated CAD/DFF40 reveals it forms a dimer (molecular scissors) with a deep active-site crevice suited for distinguishing internucleosomal from nucleosomal DNA. ICAD/DFF45 sequesters the nonfunctional CAD/DFF40 monomer and can disassemble the functional CAD/DFF40 dimer through its middle domain; caspase cleavage of ICAD/DFF45 into three domains results in self-assembly of CAD/DFF40 into the active dimer.\",\n      \"method\": \"X-ray crystallography, functional binding and disassembly assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure combined with functional validation of activation mechanism, single highly rigorous study\",\n      \"pmids\": [\"15149602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The histone H1 C-terminal domain (CTD) is responsible for activation of DFF40/CAD. The H1 CTD directly binds to DFF40/CAD and confers upon it an increased ability to bind DNA, thereby stimulating linker DNA cleavage. All six somatic cell histone H1 isoforms equally activate DFF40/CAD despite differing CTD primary sequences.\",\n      \"method\": \"Truncation mutagenesis of histone H1, direct binding assays, in vitro nuclease activity assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — truncation mutagenesis combined with binding and nuclease activity assays, multiple H1 isoforms tested\",\n      \"pmids\": [\"15910001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"HMGB1 stimulates DFF40/CAD-mediated DNA cleavage not by binding to DFF40/CAD or enhancing its DNA binding, but by inducing local DNA structural distortions through its HMG-box domains. A structural array of two HMG-boxes is required for stimulation. DNA strand cross-links (cisplatin/transplatin) mimicking HMG-box-induced distortions also affect DFF40/CAD cleavage, suggesting that DNA conformational changes induced by HMG-box binding increase substrate accessibility.\",\n      \"method\": \"In vitro nuclease assays with HMGB1 truncation mutants, DNA binding assays, cisplatin/transplatin cross-linking experiments\",\n      \"journal\": \"Acta biochimica Polonica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple truncation constructs and chemical mimics tested, single lab\",\n      \"pmids\": [\"18239742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Polyanions including RNA, single-stranded DNA, poly-glutamic acid, and heparin inhibit DFF40/CAD endonuclease by binding to the nuclease and impairing its ability to bind double-stranded DNA. Heparin is highly effective at nanomolar concentrations. The inhibitory poly-anions are proposed to bind the positively charged surface formed by alpha4 helices of the DFF40/CAD homodimer.\",\n      \"method\": \"In vitro nuclease competition assays, enzyme-inhibitor binding assays\",\n      \"journal\": \"Apoptosis : an international journal on programmed cell death\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple polyanion inhibitors tested with binding and activity assays, single lab\",\n      \"pmids\": [\"16699957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"DFF40/CAD is exclusively specific for double-stranded DNA; it does not cleave single-stranded DNA, single-stranded RNA, double-stranded RNA, or RNA-DNA heteroduplexes. Non-substrate oligonucleotides of all types competitively inhibit cleavage of double-stranded DNA. In vivo, activation of DFF40/CAD is not temporally correlated with total cellular or nuclear RNA degradation.\",\n      \"method\": \"In vitro nuclease assays with synthetic oligonucleotides of defined composition, in vivo apoptosis time-course analysis\",\n      \"journal\": \"Apoptosis : an international journal on programmed cell death\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic substrate specificity analysis in vitro with multiple substrate types plus in vivo confirmation, single lab\",\n      \"pmids\": [\"18283539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The C-terminal helix of DFF45 (residues 281-300) is dynamic and necessary for its chaperone activity toward DFF40 but not for inhibition of DFF40 nuclease activity, as determined by limited proteolysis showing residues 1-281 form a rigid domain while the C-terminal loop (residues 277-281) is trypsin-accessible.\",\n      \"method\": \"Limited proteolysis, crystallography, functional nuclease and chaperone assays\",\n      \"journal\": \"BMB reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structural and biochemical analysis separating chaperone from inhibitory functions, single lab\",\n      \"pmids\": [\"19944011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DFF40-DFF45 heterodimer localizes to the chromatin-enriched nuclear fraction under both apoptotic and non-apoptotic conditions in NB4 cells. DFF40 interacts with all H1 subtypes tested but preferentially associates with specific H1 subtypes following apoptosis induction by trichostatin A.\",\n      \"method\": \"Subcellular fractionation, MNase digestion, co-immunoprecipitation with histone H1 subtypes, apoptosis induction\",\n      \"journal\": \"Apoptosis : an international journal on programmed cell death\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — fractionation plus co-IP with functional context, single lab\",\n      \"pmids\": [\"19882353\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Oligonucleosomal DNA degradation by DFF40/CAD requires a cytosolic pool of the endonuclease. SK-N-AS neuroblastoma cells lacking cytosolic DFF40/CAD fail to undergo DNA laddering despite correct ICAD processing and caspase-3 activation; ICAD is preferentially processed in the cytosolic fraction, allowing DFF40/CAD to translocate from cytosol to chromatin-enriched fraction. Restoring cytosolic DFF40/CAD by overexpression rescues DNA laddering.\",\n      \"method\": \"Subcellular fractionation, overexpression rescue experiment, caspase activity assays, staurosporine-induced apoptosis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — fractionation, loss-of-function, and gain-of-function rescue with defined molecular readout, multiple orthogonal methods\",\n      \"pmids\": [\"22253444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In human glioblastoma cells, DFF40/CAD is improperly accumulated in the nucleoplasmic subcellular compartment rather than the cytosol, impairing oligonucleosomal DNA fragmentation during apoptosis despite correct caspase activation. Overexpression of DFF40/CAD is sufficient to restore DNA laddering after apoptotic challenge in these cells.\",\n      \"method\": \"Subcellular fractionation, overexpression rescue, immunofluorescence, apoptosis assays in GBM cells\",\n      \"journal\": \"Neuro-oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — fractionation and overexpression rescue, single lab, consistent with prior findings in neuroblastoma\",\n      \"pmids\": [\"26755073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DFFB is responsible for the first intracellular step of cell-free DNA fragmentation: analysis of cf.DNA ends in DFFB-deficient mice compared to wild-type mice establishes that DFFB generates the initial intracellular cuts in cf.DNA, with a specific cutting preference distinct from extracellular nucleases DNASE1L3 and DNASE1. The 10 bp periodicity in cf.DNA arises from cutting within intact nucleosomal structure.\",\n      \"method\": \"Nuclease-deficient mouse models, cell-free DNA end analysis, heparin disruption of nucleosomal structure\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo knockout mouse models with cf.DNA end sequencing, multiple nuclease comparisons, independent experimental validation\",\n      \"pmids\": [\"32004449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DFF40 KO Jurkat T cells generated by CRISPR-Cas9 show chemoresistance to antimetabolites (methotrexate, 6-mercaptopurine, cytarabine) and increased sensitivity to topoisomerase II inhibitors (etoposide, teniposide). DFF40 deficiency impairs histone H2AX phosphorylation following etoposide and cytarabine treatments, suggesting DFF40 regulates genomic stability in the context of chemotherapy response.\",\n      \"method\": \"CRISPR-Cas9 knockout, cell viability assays, phospho-H2AX analysis, flow cytometry\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean CRISPR KO with multiple drug treatments and molecular readouts, single lab\",\n      \"pmids\": [\"34678222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"DFF40-deficient Jurkat cells exhibit higher mitochondrial mass, increased mtDNA copy number, elevated mitochondrial membrane potential, and higher glycolysis rates (Warburg effect phenotype), with higher Mcl-1 at basal state and resistance to staurosporine- and TBT-induced apoptosis. Cell fractionation shows DFF40 can translocate to the mitochondria following apoptosis induction, suggesting a role in regulating mitochondrial function during cell death.\",\n      \"method\": \"CRISPR-Cas9 KO, cell fractionation, mitochondrial function assays, metabolic profiling\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO with multiple metabolic readouts and fractionation, single lab\",\n      \"pmids\": [\"35460011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The CIDE domain of DFF40 (and its fly orthologue DREP4) forms filament-like assemblies critical for nuclease function. DREP4 CIDE specifically binds histones H1 and H2, an interaction important for nuclease activity.\",\n      \"method\": \"Structural study, CIDE domain filament characterization, histone binding assays, nuclease activity assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structural and biochemical analysis with ortholog, single lab\",\n      \"pmids\": [\"35236824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DFF40-immunopositive proteins in intact rat liver exist primarily as a 52 kDa form. During hepatic ischemia/reperfusion, caspase-3 activation results in time-dependent accumulation of DFF40-positive fragments (40 and 20 kDa). Immunoprecipitation reveals active caspase-3 is present in the DFF40-immunopositive 20 kDa fraction, suggesting physical association of active caspase-3 with DFF40 cleavage products. Chronic alcohol administration produces similar DFF40 fragmentation.\",\n      \"method\": \"In vivo rat liver injury models, Western blotting, in vitro recombinant caspase-3 digestion, immunoprecipitation\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo model plus in vitro reconstitution with caspase-3, immunoprecipitation, single lab\",\n      \"pmids\": [\"17011520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In cancer persister cells surviving oncogene-targeted therapy, DFFB (CAD/DFF40) is sublethal activated by apoptotic caspases, induces DNA damage, mutagenesis, and upregulates ATF3. ATF3 then limits AP1-mediated interferon-stimulated gene (ISG) expression, suppressing Type I IFN signaling and enabling persister cell regrowth. DFFB-deficient persister cells exhibit high ISG expression and are unable to regrow.\",\n      \"method\": \"DFFB-deficient cell lines, ISG expression analysis, ATF3 perturbation, caspase activity assays, DNA damage assays\",\n      \"journal\": \"bioRxiv : the preprint server for biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function and pathway placement with multiple molecular readouts, preprint not yet peer-reviewed\",\n      \"pmids\": [\"40894800\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"DFFB (DFF40/CAD) is a Mg2+-dependent, double-strand-specific endonuclease that exists in an inactive heterodimeric complex with its chaperone/inhibitor DFF45 (ICAD) in the cytosol; upon apoptotic activation of caspase-3 or -7, DFF45 is cleaved and releases DFF40, which self-assembles into an active dimer (molecular scissors, as revealed by crystal structure) that translocates from cytosol to chromatin and cleaves internucleosomal linker DNA to produce oligonucleosomal ladders. Its activity is further regulated by histone H1 (which binds the enzyme, increases DNA-binding ability, and stimulates cleavage via the H1 C-terminal domain), HMGB1/2, topoisomerase II, and polyanion inhibitors, and in vivo it performs the first intracellular step of cell-free DNA fragmentation. Beyond canonical apoptosis, sublethal caspase-mediated DFFB activation in cancer persister cells induces DNA damage and ATF3 upregulation that suppresses interferon signaling to enable persister cell regrowth, and loss of DFF40 alters mitochondrial metabolism and chemotherapy sensitivity.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DFFB (DFF40/CAD) is the caspase-activated, Mg2+-dependent endonuclease that executes apoptotic internucleosomal DNA fragmentation, cleaving chromatin in the linker between nucleosomes to generate the characteristic oligonucleosomal DNA ladder [#0, #5, #7]. In healthy cells it is held inactive as a heterodimer with DFF45/ICAD, which serves dual roles as a folding chaperone required for the expression of active DFF40 and as a direct steric inhibitor that sequesters the nuclease; caspase-3 and caspase-7 cleave DFF45, releasing fragments and permitting DFF40 to self-assemble into the active enzyme [#0, #1, #14]. DFF40 is organized into an N-terminal CIDE-N regulatory domain that mediates DFF45 binding and a C-terminal catalytic domain; its NTD and the DFF45 NTD fold into each other through mutual chaperoning, and the activated enzyme forms a dimeric \\\"molecular scissors\\\" whose deep active-site crevice discriminates internucleosomal from nucleosomal DNA [#2, #8, #9]. The CIDE domain forms filament-like assemblies required for nuclease function [#21]. Catalytically the enzyme is strictly double-strand-DNA specific, requires Mg2+ and physiological K+, is inhibited by Zn2+, and produces blunt or short 5'-overhang ends bearing 5'-phosphate and 3'-hydroxyl groups [#5, #6, #13]. Its activity is positively modulated by chromatin and architectural factors — histone H1 binds DFF40 (via its C-terminal domain) to confer DNA-binding ability and increase catalytic efficiency, HMGB1 stimulates cleavage by distorting DNA structure, and polyanions such as heparin and RNA act as inhibitors [#1, #10, #11, #12]. Efficient fragmentation depends on a cytosolic pool of DFF40 that, upon cytosolic ICAD processing, translocates to chromatin; mislocalization to the nucleoplasm in tumor cells impairs DNA laddering despite intact caspase activation [#16, #17]. In vivo DFFB performs the first intracellular step of cell-free DNA fragmentation, generating the initial nucleosome-patterned cuts [#18]. Beyond canonical apoptosis, DFF40 loss alters mitochondrial mass, metabolism, and chemotherapy sensitivity [#19, #20], and sublethal caspase-mediated DFFB activation in cancer persister cells drives DNA damage and ATF3 upregulation that suppresses interferon signaling to enable regrowth [#23].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established the existence and core logic of DFFB as a caspase-activated nuclease controlled by an inhibitory partner, answering how apoptotic DNA fragmentation is triggered downstream of caspases.\",\n      \"evidence\": \"Protein purification from Jurkat cells, cDNA cloning, in vitro caspase cleavage and nuclei fragmentation assays\",\n      \"pmids\": [\"9560346\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the molecular mechanism of inhibition or the structure of the active enzyme\", \"Identity of the activating caspases not fully defined\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defined DFF45 as both chaperone and direct inhibitor, identified caspase-3/-7 (not -6/-8) as the activating proteases, and showed DFF40 oligomerizes to introduce double-strand breaks, with histone H1 as a positive cofactor.\",\n      \"evidence\": \"In vitro reconstitution, caspase cleavage, co-IP, oligomerization and kinetic assays\",\n      \"pmids\": [\"10318789\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of oligomerization unresolved\", \"Mechanism by which H1 stimulates activity not mapped\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mapped the domain architecture of DFF40 (C-terminal catalytic, N-terminal regulatory/CIDE-N) and the multi-domain binding/inhibition mechanism of DFF45, explaining how caspase cleavage relieves inhibition.\",\n      \"evidence\": \"Deletion mutagenesis, in vitro nuclease and binding assays (DFF40 domains; DFF45 D1/D2/D3 domains)\",\n      \"pmids\": [\"9867840\", \"10527861\", \"10527860\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of the heterodimer not yet available\", \"How constitutive activity is restrained in vivo unclear\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Showed the DFF45 isoform DFF35 inhibits but cannot chaperone DFF40, dissociating the chaperone and inhibitory functions and localizing them to distinct sequence regions.\",\n      \"evidence\": \"Deletion mutagenesis, nuclease and binding assays\",\n      \"pmids\": [\"10409614\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological role of DFF35 versus DFF45 in cells not established\", \"Single-lab domain mapping\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Provided rigorous biochemical definition of catalytic requirements (Mg2+, pH, dsDNA specificity, internucleosomal preference, end chemistry) and cofactor activation by H1, HMGB1, and topoisomerase II.\",\n      \"evidence\": \"In vitro endonuclease assays with defined substrates and cofactors, chromatin reconstitution\",\n      \"pmids\": [\"10713148\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of individual cofactors not dissected\", \"Structural basis of linker-DNA preference not yet shown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defined the ionic environment for activity, showing K+ in the apoptotic physiological range optimizes activity and ionic strength governs single- versus double-strand cutting.\",\n      \"evidence\": \"In vitro endonuclease assays under varied ionic conditions\",\n      \"pmids\": [\"11330826\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study, single lab\", \"In vivo confirmation of K+ dependence absent\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Genetically established that CAD/DFF40 is required specifically for oligonucleosomal fragmentation and final nuclear disassembly but dispensable for HMW cleavage and early chromatin condensation.\",\n      \"evidence\": \"CAD-/- DT40 chicken knockout cells, DNA fragmentation and apoptotic morphology analysis\",\n      \"pmids\": [\"11577114\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of nucleases responsible for HMW cleavage not addressed\", \"Avian model; mammalian in vivo requirement shown later\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Solved the solution structure of the DFF40/DFF45 NTD complex, revealing mutual chaperoning via coupled folding and an intermolecular hydrophobic core.\",\n      \"evidence\": \"NMR solution structure of heterodimeric NTDs with binding analysis\",\n      \"pmids\": [\"11371636\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the full catalytic domain not resolved here\", \"Does not show the active dimer conformation\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Crystal structure of activated CAD revealed the dimeric 'molecular scissors' architecture and explained how ICAD sequesters monomer and disassembles the dimer, completing the activation mechanism.\",\n      \"evidence\": \"X-ray crystallography with functional binding and disassembly assays\",\n      \"pmids\": [\"15149602\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of enzyme bound to DNA/nucleosome not determined\", \"Filament-level assembly not captured\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identified the histone H1 C-terminal domain as the activating element that binds DFF40 and enhances its DNA binding, mechanistically explaining chromatin-dependent stimulation.\",\n      \"evidence\": \"H1 truncation mutagenesis, binding and nuclease assays across H1 isoforms\",\n      \"pmids\": [\"15910001\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the H1 CTD–DFF40 interaction unresolved\", \"Why isoforms are functionally equivalent despite sequence divergence unexplained\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Distinguished cofactor mechanisms: HMGB1 stimulates cleavage by distorting DNA structure rather than binding the enzyme, while polyanions inhibit by blocking DFF40 DNA binding.\",\n      \"evidence\": \"In vitro nuclease assays with HMGB1 and polyanion truncations/mimics, binding assays\",\n      \"pmids\": [\"18239742\", \"16699957\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological concentrations and relevance of polyanion inhibition in cells unclear\", \"Single-lab studies\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Confirmed strict double-stranded DNA substrate specificity and showed non-substrate nucleic acids act as competitive inhibitors, ruling out RNA degradation as a DFF40 function.\",\n      \"evidence\": \"In vitro assays with defined oligonucleotides plus in vivo apoptosis time-course\",\n      \"pmids\": [\"18283539\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Competitive inhibition relevance in vivo not quantified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Separated DFF45 chaperone activity (requiring its dynamic C-terminal helix) from its inhibitory activity, refining the structural basis of the two ICAD functions.\",\n      \"evidence\": \"Limited proteolysis, crystallography, chaperone and nuclease assays\",\n      \"pmids\": [\"19944011\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo consequence of selectively disabling chaperone function not tested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated chromatin-associated localization of the DFF40–DFF45 heterodimer and preferential H1-subtype association upon apoptosis, linking biochemistry to subnuclear positioning.\",\n      \"evidence\": \"Subcellular fractionation, MNase digestion, co-IP with H1 subtypes in NB4 cells\",\n      \"pmids\": [\"19882353\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of subtype preference unclear\", \"Single cell line\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established that a cytosolic pool of DFF40 and its proper cytosol-to-chromatin translocation are required for laddering; mislocalization (nucleoplasmic accumulation) impairs fragmentation despite intact caspase signaling.\",\n      \"evidence\": \"Subcellular fractionation, loss- and gain-of-function rescue in neuroblastoma and glioblastoma cells\",\n      \"pmids\": [\"22253444\", \"26755073\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular machinery controlling translocation unidentified\", \"Why tumor cells mislocalize DFF40 unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed in vivo that DFFB executes the first intracellular cut in cell-free DNA with a distinct, nucleosome-patterned cutting preference, defining its role in cf.DNA biogenesis.\",\n      \"evidence\": \"DFFB-deficient mouse models with cf.DNA end sequencing and nuclease comparisons\",\n      \"pmids\": [\"32004449\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relationship between intracellular DFFB cuts and downstream extracellular processing only partly resolved\", \"Tissue sources of cf.DNA not fully dissected\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Revealed non-apoptotic and structural roles: CIDE-domain filament assembly is required for nuclease function, and DFF40 loss reprograms mitochondrial mass and metabolism while DFF40 can translocate to mitochondria during cell death.\",\n      \"evidence\": \"CIDE filament structural study with histone binding (DREP4 ortholog); CRISPR KO Jurkat cells with metabolic profiling and fractionation\",\n      \"pmids\": [\"35236824\", \"35460011\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking DFF40 to mitochondrial metabolism unknown\", \"Functional role of mitochondrial DFF40 undefined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Linked DFF40 to chemotherapy response and genomic stability, with KO cells showing differential drug sensitivity and impaired H2AX phosphorylation.\",\n      \"evidence\": \"CRISPR-Cas9 KO Jurkat cells, viability assays, phospho-H2AX analysis\",\n      \"pmids\": [\"34678222\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of impaired DNA damage signaling unclear\", \"Single cell type\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Implicated sublethal DFFB activation in cancer persistence, where caspase-driven DNA damage and ATF3 upregulation suppress interferon signaling to permit persister regrowth.\",\n      \"evidence\": \"DFFB-deficient cell lines, ISG and ATF3 perturbation, caspase and DNA damage assays (preprint)\",\n      \"pmids\": [\"40894800\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not yet peer-reviewed\", \"Direct molecular link from DFFB activity to ATF3 induction not fully resolved\", \"Generality across tumor types untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How DFF40's cytosol-to-chromatin (and mitochondrial) translocation is controlled, and the structural basis of its engagement with nucleosomal substrate, remain open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of DFF40 bound to nucleosomal/linker DNA\", \"Trafficking machinery for translocation unidentified\", \"Mechanistic basis of non-apoptotic metabolic and persister phenotypes incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [0, 1, 5, 7, 13]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 5, 6]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [5, 10, 12, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [16, 17]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [5, 7, 15, 16]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [17]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 1, 7, 16]}\n    ],\n    \"complexes\": [\"DFF40–DFF45 (CAD–ICAD) heterodimer\"],\n    \"partners\": [\"DFFA\", \"HIST1H1 (histone H1)\", \"HMGB1\", \"CASP3\", \"CASP7\", \"TOP2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}